News Archives - Page 364 of 702

ThursdayAug 05, 2021 1:51 pm

reAlpha Is ‘One to Watch’

The company has the ability to rent out properties on Airbnb at scale reAlpha has raised more than $6 million in two funding rounds led by $1.3 billion real estate group Crawford Hoying As of July 2021, reAlpha is testing the waters on a Reg A public offering to raise $75 million The company plans to spend $1.5 billion to acquire short-term rental properties reAlpha’s use of technology and relationships with lending institutions allow it to analyze thousands of properties per minute and purchase hundreds of properties at a time reAlpha forecasts annual revenue of $434 million by 2025 The…

ThursdayAug 05, 2021 1:31 pm

FingerMotion Inc. (FNGR) Applies for NASDAQ Uplisting

FingerMotion recently announced it has submitted an application to be uplisted to NASDAQ The company believes listing its shares of common stock on the Nasdaq Capital Market, which is subject to approval and fulfillment of applicable requirements, will improve liquidity, increase its corporate visibility, and enhance shareholder value FingerMotion’s first upgrade came in February 2019, when it announced it had been uplisted and approved to trade on the OTCQB Venture Marketplace In January 2021, the company was again uplisted to the OTCQX, where it currently trades and will continue trading until its application to join the NASDAQ is approved FingerMotion…

ThursdayAug 05, 2021 1:22 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Present Flagship PFN Program at 2021 Canaccord Genuity Virtual Growth Conference

The company will present an overview of business operations and its pipeline, including the Psilocybin-For-Neuropsychiatric Disorders (“PFN”) program for chronic pain and eating disorders The initial indication of lead drug candidate TRP-8802 is for fibromyalgia, but Tryp believes that psilocybin can be used for much more in the realm of unmet medical needs PFN’s development for its proprietary drug candidate, TRP-8803, focuses on increased efficacy, natural blood-brain barrier penetration, enhanced safety and toxicity profiles, reduced risk of abuse, and reduced risk of addiction Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a San Diego-based pharmaceuticals company, has joined the lineup of presenters…

ThursdayAug 05, 2021 1:15 pm

Grapefruit USA Inc. (GPFT) Signs Agreement with Leading Canadian Cannabis Manufacturer to Offer Game-Changing THC/CBD Cream

GPFT forms strategic alliance with 6PAK Solutions Inc Company working to achieve goal of launching Hourglass in Canada in the third quarter of 2021 Grapefruit’s patented Hourglass delivery cream system has fundamentally changed the way humans absorb cannabinoids In the United States, Grapefruit USA (OTCQB: GPFT) provides consumers with one of the most effective cannabis topical creams on the market. Now, through its partnership with 6PAK Solutions Inc., Grapefruit can offer its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream in Canada too (https://ibn.fm/ofMBY). “We are very encouraged by 6PAK’s decision to form an alliance with Grapefruit to take…

ThursdayAug 05, 2021 12:12 pm

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Marks Milestone Moment as First Psychedelic Biotech to Trade on NYSE American Exchange

Company announces official approval for its common shares to be listed, traded on NYSE American Cybin will commit resources to reach the broadest investor audience, accelerate efforts to position Cybin as sector leader Companies that list on NYSE American can leverage a wide range of advantages In an historic move, Cybin (NEO: CYBN) (NYSE American: CYBN) will become the first psychedelic biotech company to trade on the NYSE American LLC stock exchange (https://ibn.fm/LQryy). Cybin received official approval for its common shares to be listed and traded on NYSE American last week, and the company anticipates that shares will start trading…

ThursdayAug 05, 2021 12:04 pm

Brain Scientific Inc.’s (BRSF) Rapid Response EEG Devices Provide Cost-Effective Solution for Neurology Market

Patented NeuroCap(TM) and NeuroEEG(TM) devices can be used anywhere, ideal for clinical research labs, neurology clinics, urgent care clinics, emergency departments, ICUs, assisted living facilities, and nursing homes Current global market for EEG devices estimated at $956.1 million in 2020, expected to reach $1.6 billion revenue by 2026, CAGR of 8.7% between 2019-2026 Brain Scientific (OTCQB: BRSF), a commercial-stage healthcare company, focuses on developing cost-effective next-generation medical devices and software with the goal of modernizing and increasing accessibility to brain diagnostics for the rapidly growing neurology market. Brain Scientific’s patented NeuroCap(TM) and NeuroEEG(TM) devices are positioned to disrupt the expensive…

ThursdayAug 05, 2021 11:52 am

DSG Global Inc. (DSGT) Anticipates Immediate Income Potential Following Acquisition

Company enters into MOU to acquire auto import/export company Opportunities are to maintain excellence, leverage channels to grow sales DSG anticipates seeing impressive results soon after closing, plans to increase cash flow with positive revenue In a move that provides immediate sales opportunities, DSG Global (OTCQB: DSGT) announced that it has entered into a binding memorandum of understanding to acquire MTG Inc., an established automotive import/export company based in Ontario (https://ibn.fm/gZE00). MTG operates in Canada, the United States and Mexico and has extensive commercial fleet and retail connections throughout the global automotive industry. “We are acquiring a proven entity and…

WednesdayAug 04, 2021 2:17 pm

AnPac Bio-Science Co., Ltd. Continues To Build On Its Success With What Many Thought Impossible – Multiple Cancer Screening

Summary After ten years of hard work, the pan-cancer screening concept and efforts led by AnPac Bio-Science Co., Ltd. (“AnPac Bio”; NASDAQ: ANPC) since 2010 is gaining market acceptance and traction. AnPac Bio’s cancer screening technology uses sensors fabricated by integrated circuit (IC) process to detect multiple cancers in the blood at the same time. According to US marketing research firm Frost-Sullivan, AnPac Bio ranked top three globally in terms of clinical and commercial test sample numbers in the space of new cancer detection technologies in 2019. In the next five years, AnPac Bio strives to become a global leader…

WednesdayAug 04, 2021 11:44 am

American Cannabis Partners Success Lies in the Details and its Values

ACP operates in two states and has strategic plans in place to expand into two more by 2024 Partnerships have allowed the recreation of the exact soil conditions, growing supplements, water makeup, and environment of Orange Hill in Jamacia Junior Gordon, the Cultivation Manager of ACP, is an award-winning and highly sought after grower whose focus is primarily on plant health The privately-owned American Cannabis Partners ("ACP"), a large scale organic cannabis cultivation company, is headquartered in Northern California but also has a foothold in Michigan. Since its beginning in 2018, ACP has acquired 12 cannabis licenses, 20,000 sq. ft of…

WednesdayAug 04, 2021 11:34 am

FuelPositive Corp. (TSX.V: NHHH) (OTCQB: NHHHF) Hires Co-Inventor of Flagship Technology as Lead Project Engineer

FuelPositive is providing commercially viable and sustainable clean energy solutions through its flagship and proprietary technology for carbon-free ammonia The majority of ammonia used today (80%) is in the agriculture industry, with more minute percentages in waste, water treatment, antiseptic, refrigerants, textile, mining, and pharmaceuticals Co-inventor and engineer Dr. Ghassan Chehade has accepted the position of Lead Project Engineer with FuelPositive Corp. FuelPositive selected Natural Compressed Air Canada Ltd. to undertake the manufacturing of the Company’s second phase hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production The existing global ammonia market is expected to grow from $52.71 billion in…

Site Search

Company Search

Category: News